Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers
Clinical trial NCT02912247 · COMPLETED
Trial details
- NCT number
- NCT02912247
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-27
- Primary completion
- 2017-09-22
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.